Patent · US Active

Anti-CD40 antibodies

US8591900B2 · kind B2 · utility

18Cited by

0References

42Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Rachel Rebecca Barrett · Bethel, US
Scott Ronald Brodeur · New Hope, US
Keith Canada · Southbury, US
Tobias Litzenburger · Mittelbiberach, DE
Sanjaya Singh · Sandy Hook, US

Key dates

Filing date	Mar 30, 2011
Grant date	Nov 26, 2013
Priority date	—
Expiry date	Mar 8, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.